Protocol No.: VX17-445-105

Title
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Principal Investigator
Moffett, Kathryn S
Phase
III
Age Group
Both
Applicable Disease Site
Other
Participating Institution
Health Sciences Center
Contact
Tammy Clark, RN
Study Coordinator/Research Nurse
Phone: +1 304-293-5264